These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32258852)

  • 1. Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective Study.
    Muscatello A; Nozza S; Fabbiani M; De Benedetto I; Ripa M; Dell'acqua R; Antinori A; Pinnetti C; Calcagno A; Ferrara M; Focà E; Quiros-Roldan E; Ripamonti D; Campus M; Maurizio Celesia B; Torti C; Cosco L; Di Biagio A; Rusconi S; Marchetti G; Mussini C; Gulminetti R; Cingolani A; D'ettorre G; Madeddu G; Franco A; Orofino G; Squillace N; Gori A; Tambussi G; Bandera A;
    Pathog Immun; 2020; 5(1):8-33. PubMed ID: 32258852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort.
    Taramasso L; Fabbiani M; Nozza S; De Benedetto I; Bruzzesi E; Mastrangelo A; Pinnetti C; Calcagno A; Ferrara M; Bozzi G; Focà E; Quiros-Roldan E; Ripamonti D; Campus M; Celesia BM; Torti C; Cosco L; Di Biagio A; Rusconi S; Marchetti G; Mussini C; Gulminetti R; Cingolani A; d'Ettorre G; Madeddu G; Franco A; Orofino G; Squillace N; Muscatello A; Gori A; Antinori A; Tambussi G; Bandera A;
    HIV Med; 2020 Sep; 21(8):523-535. PubMed ID: 32578947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of HIV DNA decay and immune recovery between early and chronic HIV-infected individuals 96 weeks after ART.
    Qin Y; Song T; Su B; Jiao Y; Liu L; Liu Z; Zhou Y; Chen Y; Wu H
    HIV Med; 2022 Mar; 23 Suppl 1():6-13. PubMed ID: 35293100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological and virological efficacy of different antiretroviral regimens initiated during acute/recent HIV infection.
    Ambrosioni J; Farrera J; de Lazzari E; Nicolás D; Manzardo C; Hernández-Meneses MM; Mosquera MM; Ligero C; Marcos MA; Sánchez-Palomino S; Fernández E; Plana M; Miró JM;
    AIDS; 2020 Dec; 34(15):2269-2274. PubMed ID: 32910066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
    Penazzato M; Prendergast AJ; Muhe LM; Tindyebwa D; Abrams E
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004772. PubMed ID: 24852077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cohort profile: the Netherlands Cohort Study on Acute HIV infection (NOVA), a prospective cohort study of people with acute or early HIV infection who immediately initiate HIV treatment.
    Dijkstra M; Prins H; Prins JM; Reiss P; Boucher C; Verbon A; Rokx C; de Bree G
    BMJ Open; 2021 Nov; 11(11):e048582. PubMed ID: 34845066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection.
    Ananworanich J; Sacdalan CP; Pinyakorn S; Chomont N; de Souza M; Luekasemsuk T; Schuetz A; Krebs SJ; Dewar R; Jagodzinski L; Ubolyam S; Trichavaroj R; Tovanabutra S; Spudich S; Valcour V; Sereti I; Michael N; Robb M; Phanuphak P; Kim JH; Phanuphak N
    J Virus Erad; 2016; 2(1):43-48. PubMed ID: 26889497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial.
    Bruzzesi E; Gabrieli A; Bernasconi D; Marchetti G; Calcagno A; Ripamonti D; Antinori A; Squillace N; Cingolani A; Muscatello A; Bandera A; Gori A; Rusconi S; Nozza S;
    J Med Virol; 2023 Sep; 95(9):e29114. PubMed ID: 37752816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of suboptimal CD4
    Handoko R; Colby DJ; Kroon E; Sacdalan C; de Souza M; Pinyakorn S; Prueksakaew P; Munkong C; Ubolyam S; Akapirat S; Chiarella J; Krebs S; Sereti I; Valcour V; Paul R; Michael NL; Phanuphak N; Ananworanich J; Spudich S;
    J Int AIDS Soc; 2020 Sep; 23(9):e25585. PubMed ID: 32949118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal analysis of immune reconstitution and metabolic changes in women living with HIV: A real-world observational study.
    Wang X; Xiao J; Zhang L; Liu Y; Chen N; Deng M; Song C; Liu T; Zhang Y; Zhao H
    Chin Med J (Engl); 2023 Sep; 136(18):2168-2177. PubMed ID: 37580056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy.
    Fabbiani M; Borghetti A; Squillace N; Colafigli M; Taramasso L; Lombardi A; Rossetti B; Ciccullo A; Colella E; Picarelli C; Berruti M; Latini A; Montagnani F; Sambo M; Di Biagio A; Gori A; Di Giambenedetto S; Bandera A
    J Acquir Immune Defic Syndr; 2021 Jan; 86(1):119-127. PubMed ID: 33306566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced immunovirological response in women compared to men after antiretroviral therapy initiation during acute and early HIV-1 infection: results from a longitudinal study in the French ANRS Primo cohort.
    Novelli S; Delobel P; Bouchaud O; Avettand-Fenoel V; Fialaire P; Cabié A; Souala F; Raffi F; Catalan P; Weiss L; Meyer L; Goujard C
    J Int AIDS Soc; 2020 Apr; 23(4):e25485. PubMed ID: 32333726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 ​cells/mm
    Han WM; Ubolyam S; Apornpong T; Kerr SJ; Hansasuta P; Gatechompol S; Maekanantawat W; Ruxrungtham K; Phanuphak P; Ananworanich J; Avihingsanon A
    J Virus Erad; 2020 Sep; 6(3):100005. PubMed ID: 33251023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia.
    Wolday D; Legesse D; Kebede Y; Siraj DS; McBride JA; Striker R
    PLoS One; 2020; 15(10):e0240880. PubMed ID: 33091053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Better Virological Outcomes Among People Living With Human Immunodeficiency Virus (HIV) Initiating Early Antiretroviral Treatment (CD4 Counts ≥500 Cells/µL) in the HIV Prevention Trials Network 071 (PopART) Trial in South Africa.
    Fatti G; Grimwood A; Nachega JB; Nelson JA; LaSorda K; van Zyl G; Grobbelaar N; Ayles H; Hayes R; Beyers N; Fidler S; Bock P
    Clin Infect Dis; 2020 Jan; 70(3):395-403. PubMed ID: 30877753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation.
    Crowell TA; Ritz J; Coombs RW; Zheng L; Eron JJ; Mellors JW; Dragavon J; van Zyl GU; Lama JR; Ruxrungtham K; Grinsztejn B; Arduino RC; Fox L; Ananworanich J; Daar ES;
    Clin Infect Dis; 2021 Aug; 73(3):e643-e651. PubMed ID: 33382405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective clinical study of dolutegravir- versus efavirenz-based regimen in treatment-naïve patients with advanced HIV infection in Nanjing, China.
    Zhong M; Li M; Qi M; Su Y; Yu N; Lv R; Ye Z; Zhang X; Xu X; Cheng C; Chen C; Wei H
    Front Immunol; 2022; 13():1033098. PubMed ID: 36700216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
    García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
    AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late presentation for HIV impairs immunological but not virological response to antiretroviral treatment.
    Rava M; Bisbal O; Domínguez-Domínguez L; Aleman MR; Rivero M; Antela A; Estrada V; Ribera E; Muñoz A; Iribarren JA; Moreno S; Rubio R; Jarrín I;
    AIDS; 2021 Jul; 35(8):1283-1293. PubMed ID: 33813554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.